Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

The new Cosmetic Surgery Scar Assessment Scale (CSSAS) was found to be simple and effective in evaluating scars from hair restoration surgeries.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Asparagus racemosus root extract reduced sebum and pore size in men but not in women.

The Aqualon SLT device measures hair stiffness and slipperiness to evaluate hair treatments.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

Fractional CO2 laser is more effective and safer than steroid injections for treating alopecia areata.

The AI device accurately grades scalp exfoliation and can help diagnose scalp disorders.

AI improves vascular surgery by enhancing precision and safety, but doctors make final decisions.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Women with hair loss have more androgen receptors in certain hair follicles.

Regenera Activa AMT effectively improves hair growth and reduces hair loss in androgenetic alopecia.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Alopecia areata in Saudi Arabia is costly, mainly due to lost productivity and drug costs.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

The document's conclusion cannot be summarized because the content is not accessible or understandable.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Two new enzymes, PAD-R11 and PAD-R4, were cloned and showed activity, with PAD-R11 resembling epidermal enzymes.

Rice Bran Supercritical CO2 Extract significantly increased hair density and diameter in male alopecia patients without any side effects.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.